David L. Mahoney, an insider at Corcept Therapeutics Inc. (CORT), sold 91,167 shares of the company's stock on August 18, 2026. The transactions were executed at an average price of $118.24 per share, resulting in a total value of approximately $10.78 million.
This recent sale follows other transactions by Mr. Mahoney on the same date, totaling an additional 12,439 shares. Earlier in August, another insider, William Guyer, also engaged in a sale of Corcept Therapeutics stock.
Insider sales can be attributed to various personal financial decisions, such as portfolio diversification or tax planning, and do not necessarily indicate a negative view of the company's prospects.